Relapse risk score after allogeneic stem cell transplantation for MDS patients. An EBMT study from the MDS subcommittee of Chronic Malignancies Working Party (CMWP)
Author(s):
Kroger, N.; Putter, H.; Wreede, L. de; Biezen, A. van; Ziagkos, D.; Volin, L.; Maertens, J.; Finke, J.; Ljungman, P.; Russell, N.; Yakoub-Agha, I.; Schaap, M.; Craddock, C.; Mufti, G.; Chevallier, P.; Passweg, J.; Milpied, N.; Blaise, D.; Bourhis, J.H.; Gedde-Dahl, T.; Espiga, C.R.; Cornelissen, J.; Gohring, G.; Schetelig, J.; Witte, T. de; Robin, M.; MDS Subcomm CMWP
Published
2016
Publication type
Article / Letter to editor
Date issued
2016-03-31
Language
English
Is part of
Bone Marrow Transplantation (2016), Vol. 51, p. S310-S311
